Anaphylaxis

Publication Date: December 17, 2023

Key Points

Key Points

  • Anaphylaxis is an acute, potential life-threatening systemic allergic reaction that may have a wide range of clinical manifestations.
  • Severe anaphylaxis and/or the need for repeated doses of epinephrine to treat anaphylaxis are risk factors for biphasic anaphylaxis.
  • Antihistamines and/or glucocorticoids are not reliable interventions to prevent biphasic anaphylaxis.

Diagnosis

Diagnos...

...Force suggests that a clinician incorporate...


...e Joint Task Force suggests extended clin...


Treatment

...eatment...

...Force suggests against administering glu...

...Joint Task Force suggests in favor...

...Task Force suggests against routine...

...Joint Task Force suggests in favor adminis...


...actice Statements...

...ister epinephrine as the first-line pharmacoth...

...e administration of epinephrine for anaphyla...

...osis and treatment of anaphylaxis, al...

...with anaphylaxis should receive educa...


...d Key Clinical Advice...

...Severe anaphylaxis and/or the...


Illustrat...